3D Bioprinting Market

Request for customization Inquire Before Buying

3D Bioprinting Market Size, Share and Industry Analysis Report By Component (3D Bioprinters and Bio ink); By Technology (Magnetic Levitation and Inkjet-based); By Material Type (Living Cells, Hydrogels, Extracellular Matrices);By Application (Dental, Biosensors, Medical Research and Clinical); By End user (Biopharma, Academia, Research Organizations and Hospitals) - Forecast Year 2024 – 2031

Healthcare // Biotechnology

Number of Pages: 275 Report Format: pdf Report ID: ZBA-590 Publishing Date: - January, 2023

Frequently Ask Question

The Global 3D Bioprinting Market Is Forecasted To Grow At A Rate Of 22.4% To USD 5.79 Billion In 2030.

Key Factors That Are Driving The Market Growth Include Increasing use of 3D bioprinting in pharmaceutical and cosmetology industries, Developments in 3D bioprinting for tissue and organ regeneration applications, Rising public and private funding to support bioprinting research activities

The 3D Bioprinting Market Is Led By 3D Bioprinters Segment And Is Projected To Account For The Largest Size Of The 3D Bioprinting Market From 2023 To 2030.

Some Key Players Operating In The 3D Bioprinting Market Include 3Dbio Therapeutics, Advanced Solutions Life Sciences, Llc, Allevi, Inc. (Part Of 3D Systems, Inc.), Aspect Biosystems Ltd., Bico Group AB, Brinter, Collplant Biotechnologies Ltd., Cyfuse Biomedical K.K., Envisiontec Gmbh (Part Of Desktop Metal, Inc.), Foldink Life Science Technologies, Gesim Mbh, Manchester Biogel, Organovo Holdings Inc., Pandorum Technologies Pvt. Ltd., Poietis, Precise Bio, Prellis Biologics, Regemat 3D, Regenhu, Regenovo Biotechnology Co., Ltd. (Part Of Shining 3D Tech Co., Ltd.), Revotek Co., Ltd., Rokit Healthcare, Inc., Sunp Biotech, Llc, Tissue Regeneration Systems Inc., Vivax Bio, Llc